Patents Represented by Attorney James P. Riek
  • Patent number: 8347879
    Abstract: A fluid dispensing device is disclosed having a housing and a fluid discharge device. The fluid discharge device is arranged to be actuated by one or more levers so as to apply a force transversely to the fluid discharge device which is used to move a container forming part of the fluid discharge device along a longitudinal axis of the fluid discharge device to cause actuation of a pump forming part of the fluid discharge device. A pre-load means is used to prevent actuation of the pump until a pre-determined force is applied to each lever of sufficient magnitude to guarantee the production of a well developed efficient spray from the fluid dispensing device.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: January 8, 2013
    Assignee: Glaxo Group Limited
    Inventors: Michael Birsha Davies, James W. Godfrey
  • Patent number: 8309713
    Abstract: A novel process for preparing a compound of formula (I) which comprises converting a compound of formula (II) to a compound of formula (I) via a compound of formula (III), or a salt thereof, without isolating any intermediates.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: November 13, 2012
    Assignee: Glaxo Group Limited
    Inventors: Malcolm Brian Berry, Mark Jason Hughes, David Parry-Jones, Stephen John Skittrall
  • Patent number: 8252818
    Abstract: Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: August 28, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Nicola Mary Aston, Paul Bamborough, Ann Louise Walker
  • Patent number: 8251056
    Abstract: An inhaler is provided with a closure which may be moved between a closed and open position in order to cover and uncover a mouthpiece. The closure is associated with a revolvable element including a restricting member. Movement of the closure from the open position to the closed position causes the revolvable element to revolve around an axis X thereby placing the restricting member in a restricting position which restricts relative movement between a container unit and the housing such that unintentional actuation of the inhaler is prevented. The inhaler is useful, for example, in the treatment of asthma.
    Type: Grant
    Filed: September 7, 2006
    Date of Patent: August 28, 2012
    Assignee: Glaxo Group Limited
    Inventors: Allen John Pearson, Paul Kenneth Rand
  • Patent number: 8245704
    Abstract: There is provided a dispenser suitable for dispensing medicament, particularly medicament for use in the treatment of respiratory disorders. The dispenser comprises a housing having a support; a container, locatable within said housing, having an outlet, wherein said container dispenses through said outlet in response to movement of the container relative to the housing; and an actuation indicator having an indexing mechanism actuatable by movement of the container relative to the housing. A couple mechanism is provided which couples the indexing mechanism to the container to compensate for any variation in pre-actuation positionings of the indexing mechanism and container.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: August 21, 2012
    Assignee: Glaxo Group Limited
    Inventors: Paul Kenneth Rand, Peter John Brand, James William Godfrey
  • Patent number: 8245906
    Abstract: A dose counter for use with a medicament dispenser which comprises a ratchet; a first count wheel arranged to rotate about a first axis of rotation, the first count wheel including one or more ratchet drive receipt elements arranged thereon for receipt of drive from the ratchet to rotate the first count wheel about the first axis of rotation; a second count wheel arranged to rotate about the first axis of rotation, the second count wheel including a set of teeth arranged annularly thereon; and a kick wheel arranged to rotate about a second axis of rotation offset from the first axis of rotation, the kick wheel including a set of kick teeth arranged annularly thereon and in meshed relationship with the teeth of the second count wheel such that rotary motion of the kick wheel results in rotary motion of the second count wheel is described.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: August 21, 2012
    Assignee: Glaxo Group Limited
    Inventors: Gary Thomas Crosby, David Vincent Elliman, Andrew Michael Kelly
  • Patent number: 8207176
    Abstract: The present invention is directed to novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds, compositions, and use in therapy as CSBP/RK/p38 kinase inhibitors of Formulas (V) and (Va) wherein inter alia, G5 and G6 are nitrogen and CH, provided that only one of G5 or G6 is nitrogen and the other is CH; R1 is C(Z)N(R10?)(CR10R20)vRb, C(Z)O(CR10R20)vRb, N(R10?)C(Z)(CR10R20)vRb, N(R10?)C(Z)N(R10?)(CR10R20)vRb, or N(R10?)OC(Z)(CR10R20)vRb; R1? is independently selected at each occurrence from halogen, C1-4 alkyl, halo-substituted-C1-4 alkyl, cyano, nitro, (CR10R20)v?NRdRd?, (CR10R20)v?C(O)R12, SR5, S(O)R5, S(O)2R5, or (CR10R20)v?OR13; Rb is hydrogen, C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl C1-10 alkyl, aryl, arylC1-10alkyl, heteroaryl, heteroarylC1-10 alkyl, heterocyclic, or heterocyclylC1-10 alkyl moiety, which moieties, excluding hydrogen, may all be optionally substituted; X is R2, OR2?, S(O)mR2?, (CH2)n?N(R10?)S(O)mR2?, (CH2)n?N(R10?)C(O)R2?, (CH2)n?NR4R14, (CH2)
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: June 26, 2012
    Assignee: Glaxo Group Limited
    Inventors: James F. Callahan, Jeffrey C. Boehm, Anthony William James Cooper, Stefano Livia, Paul Bamborough, Neysa Nevins, Zehong Wan, Beth A. Norton, Xichen Lin
  • Patent number: 8165892
    Abstract: A method for automatically tracking compliance in a clinical trials process involving one or more operations comprising selecting a container; associating an identifier with the container, the identifier having a unique signature data item thereon; reading the unique signature data item to a relational database; performing a first operation relating to the container; checking the performance of the first operation against a compliance standard; following the successful completion of the first operation, writing an associated compliance data item to the relational database; optionally performing one or more further operations relating to the container; and following the successful completion of each optional further operation or a package thereof, writing an associated compliance data item to the database.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: April 24, 2012
    Assignee: SmithKline Beeacham P.L.C.
    Inventors: Paul Laurence Carter, Stephen Day, Peter Graham Evans, Lesley Julia George
  • Patent number: 8147461
    Abstract: A fluid dispensing device for dispensing a fluid product having a dispensing outlet from which the fluid product is dispensable, a supply of the fluid product, a dispensing member mounted for movement in a dispensing direction along an axis X-X from a first position to a second position which causes a dose of the fluid product in the supply to be dispensed from the dispensing outlet, and a finger-operable actuator member mounted for movement in an actuating direction which is generally transverse to the axis.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: April 3, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stanley George Bonney, Hugh Alexander Connell, Michael Birsha Davies, James William Godfrey, Mark Graham Hedley, Robert William Tansley
  • Patent number: 8113199
    Abstract: There is provided a dose counter for use with a medicament dispenser. The dose counter comprises a first count wheel arranged to rotate about a first axis of rotation, the first count wheel including a set of primary drive teeth arranged annularly thereon for drivable rotation of the first count wheel about the first axis of rotation; a second count wheel arranged to rotate about the first axis of rotation, the second count wheel including a set of secondary drive teeth arranged annularly thereon; and a kick wheel arranged to rotate about a second axis of rotation offset from the first axis of rotation, the kick wheel including a set of kick teeth arranged annularly thereon and in meshed relationship with the set of secondary drive teeth of the second count wheel such that rotary motion of the kick wheel results in rotary motion of the second count wheel.
    Type: Grant
    Filed: February 15, 2005
    Date of Patent: February 14, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stephen Edward Augustyn, Stephen James Harvey
  • Patent number: 8066002
    Abstract: There is provided a manifold for use in a medicament dispenser device for the delivery of medicament powder from an open blister pocket of a blister pack. The manifold comprises a body, the body defining a chimney having a chimney inlet and a chimney exit for directing airflow from the chimney inlet to the chimney exit; the body further defining a chamber having a chamber inlet and a chamber exit. The chimney exit and said chamber inlet lie side-by-side each other such that when said open blister pocket of said blister pack is positioned adjacent thereto said airflow may be directed from the chimney exit to the chamber inlet via the open blister pocket to entrain said medicament powder and enable transport thereof in the airflow from the chamber inlet to said chamber outlet. The manifold is arranged such as to delay the emptying of the medicament powder from the blister pocket.
    Type: Grant
    Filed: December 19, 2005
    Date of Patent: November 29, 2011
    Assignee: Glaxo Group Limited
    Inventors: David Prime, Richard Ian Walker
  • Patent number: 8062264
    Abstract: A fluid dispensing device for dispensing a fluid product having a dispensing member mounted for movement along an axis X-X from a first position to a second position which causes a dose of a fluid product to be dispensed, and a finger-operable actuator member movable in an actuating direction generally transverse to the axis to cause at least one cam surface thereof to cam the dispensing member from the first position to the second position. The at least one cam surface has a commitment section, oriented at a first angle to the axis selected such that a minimum actuating force is required to be applied to the actuator member to cause the at least one cam follower surface to ride over the commitment section onto the drive section. The commitment section of the cam surface is arcuate.
    Type: Grant
    Filed: April 5, 2006
    Date of Patent: November 22, 2011
    Assignee: Glaxo Group Limited
    Inventors: James William Godfrey, Mark Graham Hedley
  • Patent number: 8058282
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: November 15, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Jerry L. Adams, Jeffrey C. Boehm, Ralph Hall, Qi Jin, Jiri Kasparec, Domingos J. Silva, John J. Taggart
  • Patent number: 7989479
    Abstract: The use of 6-(S-Cyclopropylcarbamoyl-S-fluoro-2-methyl-phenyl)-N-(2,2-dimethylproyl)-nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: August 2, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Mauro Corsi, Isidore Faiferman, Emilio Merlo Pich, Emiliangelo Ratti, Paul Bryan Wren
  • Patent number: 7989629
    Abstract: The present invention relates to a compound of formula (I), or a salt thereof wherein the naphthalene ring is substituted in the 2, 3, 4, 5, 6, 7 or 8 position by R1, and R1 represents —CH2CH2COOH or —CH?C(CH3)COOH, and to processes for their preparation, to compositions containing them and to their use in the treatment of various inflammatory and/or allergic diseases, such as diseases such as allergic rhinitis.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: August 2, 2011
    Assignee: Glaxo Group Limited
    Inventors: Simon Teanby Hodgson, Panayiotis Alexandrou Procopiou, Maria Victoria Vinader Brugarolas
  • Patent number: D639931
    Type: Grant
    Filed: March 12, 2007
    Date of Patent: June 14, 2011
    Assignee: Glaxo Group Limited
    Inventors: Gregor John McLennan Anderson, Matthew Spencer Collins, David Vincent Elliman, Richard David Lintern, Andrew Michael Kelly, Allen John Pearson, Paul Kenneth Rand, Mark Digby Teucher, James Anthony West
  • Patent number: D644321
    Type: Grant
    Filed: February 8, 2011
    Date of Patent: August 30, 2011
    Assignee: Glaxo Group Limited
    Inventor: Philip William Farr
  • Patent number: D653326
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: January 31, 2012
    Assignee: Glaxo Group Limited
    Inventors: Gregor John McLennan Anderson, Matthew Spencer Collins, David Vincent Elliman, Richard David Lintern, Andrew Michael Kelly, Allen John Pearson, Paul Kenneth Rand, Mark Digby Teucher, James Anthony West
  • Patent number: D653327
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: January 31, 2012
    Assignee: Glaxo Group Limited
    Inventors: Gregor John McLennan Anderson, Matthew Spencer Collins, David Vincent Elliman, Richard David Lintern, Andrew Michael Kelly, Allen John Pearson, Paul Kenneth Rand, Mark Digby Teucher, James Anthony West
  • Patent number: D653747
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: February 7, 2012
    Assignee: Glaxo Group Limited
    Inventors: Gregor John McLennan Anderson, Matthew Spencer Collins, David Vincent Elliman, Richard David Lintern, Andrew Michael Kelly, Allen John Pearson, Paul Kenneth Rand, Mark Digby Teucher, James Anthony West